What good is a healthier school meal if fewer children can get it?

Strong nutrition policy has two inseparable goals: assuring that food served is nutritious and that everyone who needs it can get in line. We currently have an administration that claims to support healthy food access for children by improving nutritional content (an as-yet-unfulfilled promise), while also cutting funding for programs that keep children healthy and fed (a threat demonstrably fulfilled).

Food Fight: A Special Impact Report for Partners & Benefactors, Fall 2026

Moms, Pizzamakers to Gov Hochul: Kick Cancer Out of Our Food, Sign Food Safety Reform NOW!

FDA moves on peptides put consumers in harm's way

FDA's recent move to consider adding unproven peptides to the 503A Bulks List threatens public health, advisory committee integrity, and the drug approval process.

We're suing NIH, DOGE, and RFK Jr. for censoring research

CSPI is part of a class action lawsuit against NIH, HHS, and DOGE, challenging censorship of crucial research grants. Learn how to help defend public health.

NIH censors crucial research in Alzheimer's, kidney disease, & more, researchers share

NIH is targeting and terminating grants for research studies that it thinks will communicate disfavored viewpoints on diversity, gender identity, climate change, and more, violating First Amendment rights and threatening the future of public health.

Report explores what drives retailers to donate healthy food

New CSPI-Johns Hopkins-More Than Food report shows how retailers can boost nutritious food donations amid rising prices, SNAP cuts, and shrinking federal support.

Researchers challenge NIH screening of grants for disfavored viewpoints

Class action lawsuit seeks to stop NIH censorship and termination of federally funded scientific research

New study finds alcohol industry fails on nutrition, ingredient transparency

Comments RE: Pharmacy Compounding Advisory Committee meeting on bulk drug substances nominated for inclusion on the Section 503A bulk drug substance list

"The Center for Science in the Public Interest, an advocacy group that accepts no funding from industry, opposes the proposed inclusion of the seven bulk peptide drug substances (BPC-157, KPV, TB-500, MOTs-C, emideltide, semax, and epitalon) in the 503A Bulks List, allowing them to be compounded, because this action is inconsistent with the FDA’s own standards for pharmacy compounding, poses dangers to consumers, and removes incentives for developing new pharmaceutical products through the standard drug approval process.   Agency scientists recently reviewed the available data for these seven bulk drug substances in detail and recommended that all seven “NOT be included in the 503A Bulks List” (emphasis in the original) because of the overall lack of data to characterize the substances’ historical use, physical and chemical properties, safety profile, and effectiveness. We support the career scientists’ determinations and urge the committee and subsequently the agency itself to follow the recommendations of the FDA’s own subject matter experts. " View the resource below to keep reading.